Earnings Feed
Start Free
Theravance Biopharma, Inc.·4

Feb 22, 6:13 PM ET

HAUMANN BRETT K 4

4 · Theravance Biopharma, Inc. · Filed Feb 22, 2019

Insider Transaction Report

Form 4
Period: 2019-02-20
Theravance Biopharma, Inc.TBPH
HAUMANN BRETT K
SVP, Clinical Development
Transactions
  • Tax Payment

    Ordinary Shares

    2019-02-20$27.00/sh−7,778$210,006→ 239,383 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -